Adenovirus-Transduced Dendritic Cells Injected into Skin or Lymph Node Prime Potent Simian Immunodeficiency Virus-Specific T Cell Immunity in Monkeys

Journal of Immunology

Volumn 171, Issue 12, 2003, Pages 6875-6882

  Brown, Kevin ^a   Gao, Wentao ^b   Alber, Sean ^b   Trichel, Anita ^b   Murphey Corb, Michael ^b   Watkins, Simon C ^b   Gambotto, Andrea ^b   Barratt Boyes, Simon M ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CD8 ANTIGEN; DNA VACCINE; EPITOPE; GAG PROTEIN; SIMIAN IMMUNODEFICIENCY VIRUS VACCINE;

ADENOVIRUS; AMINO ACID SEQUENCE; ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; BIOSYNTHESIS; CANCER; CELL CULTURE; CELL LINE; CELL MOTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOLOGY; DENDRITIC CELL; EMBRYO; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTHESIS; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; IMMUNOLOGY; INTRADERMAL DRUG ADMINISTRATION; INTRALYMPHATIC DRUG ADMINISTRATION; LYMPH NODE; MACACA; MALE; MONKEY DISEASE; MONOCYTE; NONHUMAN; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; RHESUS MONKEY; SIMIAN IMMUNODEFICIENCY VIRUS; SKIN; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TRANSPLANTATION; VIROLOGY; VIRUS STRAIN;

EID: 0347627711     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.12.6875     Document Type: Article

References (47)

1. Fong, L., and E. G. Engleman. 2000. Dendritic cells in cancer immunotherapy. Annu. Rev. Immunol. 18:245.
2. Steinman, R. M., and M. Dhodapkar. 2001. Active immunization against cancer with dendritic cells: the near future. Int. J. Cancer 94:459.
3. Piguet, V., and A. Blauvelt. 2002. Essential roles for dendritic cells in the pathogenesis and potential treatment of HIV disease. J. Invest. Dermatol. 119:365.
4. O'Connor, D. H., T. M. Allen, T. U. Vogel, P. Jing, I. P. DeSouza, E. Dodds, E. J. Dunphy, C. Melsaether, B. Mothe, H. Yamamoto, et al. 2002. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection. Nat. Med. 8:493.
5. Bhardwaj, N., and B. D. Walker. 2003. Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine. Nat. Med. 9:13.
6. Nestle, F. O., S. Alijagic, M. Gilliet, Y. Sun, S. Grabbe, R. Dummer, G. Burg, and D. Schadendorf. 1998. Vaccination of melanoma patients with peptide or tumor lysate-pulsed dendritic cells. Nat. Med. 4:328.
7. Thurner, B., I. Haendle, C. Roder, D. Dieckmann, P. Keikavoussi, H. Jonuleit, A. Bender, C. Maczek, D. Schreiner, P. von den Driesch, et al. 1999. Vaccination with mage-3A1 peptide-pulsed mature, monocyte-derived dendritic cells expands specific cytotoxic T cells and induces regression of some metastases in advanced stage IV melanoma. J. Exp. Med. 190:1669.
8. Knutson, K. L., K. Schiffman, and M. L. Disis. 2001. Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients. J. Clin. Invest. 107:477.
9. Jonuleit, H., A. Giesecke-Tuettenberg, T. Tuting, B. Thurner-Schuler, T. B. Stuge, L. Paragnik, A. Kandemir, P. P. Lee, G. Schuler, J. Knop, and A. H. Enk. 2001. A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection. Int. J. Cancer 93:243.
10. Schuler-Thurner, B., E. S. Schultz, T. G. Berger, G. Weinlich, S. Ebner, P. Woerl, A. Bender, B. Feuerstein, P. O. Fritsch, N. Romani, and G. Schuler. 2002. Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells. J. Exp. Med. 195:1279.
11. + T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyngeal carcinoma. Cancer Res. 62:6952.
12. Lu, W., X. Wu, Y. Lu, W. Guo, and J. M. Andrieu. 2003. Therapeutic dendriticcell vaccine for simian AIDS. Nat. Med. 9:27.
13. Jenne, L., G. Schuler, and A. Steinkasserer. 2001. Viral vectors for dendritic cell-based immunotherapy. Trends Immunol. 22:102.
14. Ignatius, R., M. Marovich, E. Mehlhop, L. Villamide, K. Mahnke, W. I. Cox, F. Isdell, S. S. Frankel, J. R. Mascola, R. M. Steinman, and M. Pope. 2000. Canarypox virus-induced maturation of dendritic cells is mediated by apoptotic cell death and tumor necrosis α factor secretion. J. Virol. 74:11329.
15. Dietz, A. B.. and S. Vuk-Pavlovic., 1998. High efficiency adenovirus-mediated gene transfer to human dendritic cells. Blood 91:392.
16. Zhong, L., A. Granelli-Piperno, Y. Choi, and R. M. Steinman. 1999. Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells. Eur. J. Immunol. 29:964.
17. Zhong, L., A. Granelli-Piperno, M. Pope, R. Ignatius, M. G. Lewis. S. S. Frankel, and R. M. Steinman. 2000. Presentation of SIVgag to monkey T cells using dendritic cells transfected with a recombinant adenovirus. Eur. J. Immunol. 30:3281.
18. Brossart, P., A. W. Goldrath, E. A. Butz, S, Martin, and M. J. Bevan. 1997. Virus-mediated delivery of antigenic epitopes into dendritic cells as a means to induce CTL. J. Immunol. 158:3270.
19. Song, W., H. L. Kong, H. Carpenter, H. Torii. R. Granstein., S. Rafii, M. A. Moore, and R. G., Crystal. 1997. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity. J. Exp. Med. 186:1247.
20. Harshyne, L. A., S. C. Watkins, A. Gambotto. and S. M. Barratt-Boyes. 2001. Dendritic cells acquire antigens from live cells for cross-presentation to CTL. J. Immunol. 166:3717.
21. Barratt-Boyes, S. M., M. I. Zimmer, L. A. Harshyne, E. M. Meyer, S. C. Watkins, S. Capuano III, M. Murphey-Corb, L. D. Falo, Jr., and A. D. Donnenberg. 2000. Maturation and trafficking of monocyte-derived dendritic cells in monkeys: implications for dendritic cell-based vaccines. J. Immunol. 164:2487.
22. Harshyne, L. A., M. I. Zimmer, S. C. Watkins, and S. M. Barratt-Boyes. 2003. A role for class A scavenger receptor in dendritic cell nibbling from live cells. J. Immunol. 170:2302.
23. Barratt-Boyes, S. M., S. C. Watkins, and O. J. Finn. 1997. In vivo migration of dendritic cells differentiated in vitro: a chimpanzee model. J. Immunol. 158:4543.
24. Dhodapkar, M. V., R. M. Steinman, J. Krasovsky, C. Munz, and N. Bhardwaj. 2001. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J. Exp. Med. 193:233.
25. + T-cell response to human cytomegalovirus the 72-kilodalton major immediate-early protein revisited. J. Virol. 73:8179.
26. Tobery, T. W., S. Wang, X. M. Wang, M. P. Neeper, K. U. Jansen, W. L. McClements, and M. J. Caulfield. 2001. A simple and efficient method for the monitoring of antigen-specific T cell responses using peptide pool arrays in a modified ELISPOT assay. J. Immunol. Methods 254:59.
27. Rosenberg, S. A., Y. Zhai, J. C. Yang, D. J. Schwartzentruber, P. Hwu, F. M. Marincola, S. L. Topalian, N. P. Restifo, C. A. Seipp, J. H. Einhorn, et al. 1998. Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens, J. Natl. Cancer Inst. 90:1894.
28. Yang, Y., Q. Li, H. C. Ertl, and J. M. Wilson. 1995. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69:2004.
29. Miller, G., S. Lahrs, V. G. Pillarisetty, A. B. Shah, and R. P. DeMatteo. 2002. Adenovirus infection enhances dendritic cell immunostimulatory properties and induces natural killer and T-cell-mediated tumor protection. Cancer Res. 62:5260.
30. Avvakumov, N., R. Wheeler, J. C. D'Halluin, and J. S. Mymryk. 2002. Comparative sequence analysis of the largest EIA proteins of human and simian adenoviruses. J. Virol. 76:7968.
31. Zimmer, M. I., A. T. Larregina, C. M. Castillo. S. Capuano III, L. D. Falo, Jr., M. Murphey-Corb, T. A. Reinhart, and S. M. Barratt-Boyes. 2002, Disrupted homeostasis of Langerhans cells and interdigitating dendritic cells in monkeys with AIDS. Blood 99:2859.
32. Ranieri, E., W. Herr, A. Gambotto, W. Olson, D. Rowe, P. D. Robbins, L. S. Kierstead, S. C. Watkins, L. Gesualdo, and W. J. Storkus. 1999. Dendritic cells transduced with an adenovirus vector encoding Epstein-Barr virus latent membrane protein 2B: a new modality for vaccination. J. Virol. 73:10416.
33. + T-cell in humans without foreign helper epitopes. J. Clin. Invest. 105:R9.
34. Casimiro, D. R., L. Chen, T. M. Fu, R. K. Evans, M. J. Caulfield, M. E. Davies, A. Tang, M. Chen, L. Huang, V. Harris, et al. 2003. Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type I gag gene. J. Virol. 77:6305.
35. Gandhi, R. T., and B. D. Walker. 2002, Immunologic control of HIV-1. Annu. Rev. Med. 53:149.
36. + T cells using dendritic cells transfected with RNA encoding a chimeric gene product, Cancer Res. 62:5041.
37. Kuroda, M. J., J. E. Schmitz, D. H. Barouch, A. Craiu, T. M. Allen, A. Sette, D. I. Watkins, M. A. Forman. and N. L. Letvin. 1998. Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex. J. Exp. Med. 187:1373.
38. + lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class 1 molecule Mamu-A*01: implications for vaccine design and testing. J. Virol. 75:738.
39. Vogel, T. U., T. C. Friedrich, D. H. O'Connor, W. Rehrauer, E. J. Dodds, H. Hickman, W. Hildebrand, J. Sidney, A. Sette, A. Hughes, et al. 2002. Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class 1 molecule, Mamu-A*02: a paradigm for virus evolution and persistence? J. Virol. 76:11623.
40. Gao, W., P. D. Robbins, and A. Gambotto. 2003. Human adenovirus type 35: nucleotide sequence and vector development. Gene Ther. 10:1941.
41. Morse, M. A., R. E. Coleman. G. Akabani, N. Niehaus, D. Coleman, and H. K. Lyerly, 1999. Migration of human dendritic cells after injection in patients with metastatic malignancies. Cancer Res. 59:56.
42. + hematopoietic progenitor cells. Immunol. Immunother. 48:118.
43. De Vries, I. J., D. J. Krooshoop, N. M. Scharenborg, W. J. Lesterhuis, J. H. Diepstra, G. N. Van Muijen, S. P. Strijk, T. J. Ruers, O. C. Boerman. W. J. Oyen, et al. 2003. Effective migration of antigen-pulsed dendritic cells to lymph nodes in melanoma patients is determined by their maturation state, Cancer Res. 63:12.
44. Fong, L., D. Brockstedt, C. Benike, L. Wu, and E. G. Engleman. 2001. Dendritic cells injected via different routes induce immunity in cancer patients. J. Immunol. 166:4254.
45. Choi, Y. K., B. A. Fallert, M. A. Murphey-Corb, and T. A. Reinhart. 2003. Simian immunodeficiency virus dramatically alters expression of homeostatic chemokines and dendritic cell markers during infection in vivo. Blood 101:1684.
46. Barouch, D. H., J. Kunstman, M. J. Kuroda, J. E. Schmitz, S. Santra, F. W. Peyerl, G. R. Krivulka, K. Beaudry, M. A. Lifton, D. A. Gorgone, et al. 2002. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 415:335.
47. Gao, W., A. Rzewski, H. Sun, P. D. Robbins, and A. Gambotto. UpGene: application of a web-based DNA codon optimization algorithm. Biotechnol. Progr. In press.